← All companies
NEUROCRINE BIOSCIENCES INC
NBIX - CIK 0000914475
Market cap$16.17 B
Rank#700
SEC filings2,097
The table below shows NEUROCRINE BIOSCIENCES INC's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $713.00M | $233.00M | $251.10M | $262.90M | $340.80M | $187.10M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $686.80M | $479.10M | - | $350.00M | $185.50M | $157.10M |
| Inventory | $69.00M | $57.40M | $38.30M | $35.10M | $30.50M | $28.00M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.